Welcome to our dedicated page for Herbalife SEC filings (Ticker: HLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Herbalife Ltd. filings document the regulatory record of a Cayman Islands health and wellness company with common shares listed on the New York Stock Exchange under HLF. Form 8-K reports cover quarterly and annual financial results, Regulation FD materials, material definitive agreements, senior secured notes due 2033, and amendments to secured credit facilities involving company subsidiaries.
Proxy materials cover annual general meeting procedures, shareholder voting matters, and governance. The filings also describe capital-structure subjects, security registration details, and formal disclosures related to the company’s products, network marketing program, and legal or regulatory risk areas.
LEVITT MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Michael J. Levitt received an equity grant in the form of 11,879 restricted stock units (RSUs) on May 8, 2026. The award was granted at no cash cost per unit and was made under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, as long as Levitt continues to serve on the Board of Directors through that date. After this grant, his directly held equity position reported in this filing totals 49,393 shares or units of common stock-based holdings.
Mendoza Juan Miguel reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Juan Miguel Mendoza received a grant of 11,879 shares of common stock in the form of restricted stock units (RSUs). The award was granted at no cash cost per share and is part of his equity compensation.
The RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, as long as he continues serving on the company’s Board of Directors through that date. After this grant, Mendoza holds a total of 181,879 shares of common stock directly.
Walsh Des reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Des Walsh received an equity grant of 11,879 shares of Common Stock in the form of restricted stock units under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These RSUs carry no cash purchase price.
The RSUs will vest 100% on April 15, 2027, as long as Walsh continues to serve on the company’s Board of Directors through that date. After this award, he holds 61,879 shares directly and 200,000 shares indirectly through a trust.
HERBALIFE LTD. director Rodica Macadrai received a grant of 11,879 shares of Common Stock in the form of restricted stock units as compensation. The award carries no cash exercise price. After this grant, she directly holds 67,441 shares in total.
The restricted stock units were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, provided she continues to serve on the Board of Directors through that date.
Mulligan Donal L reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Donal L. Mulligan reported an equity award. He received 11,879 shares of Common Stock in the form of restricted stock units granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan at no cash cost.
The RSUs will vest 100% on April 15, 2027, if he continues to serve on the Board through that date. After this grant, he directly holds 68,982 shares of Common Stock and also has an indirect holding of 60,000 shares held by a trust.
L'Helias Sophie reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Sophie L’Helias reported receiving an equity award of 11,879 shares of Common Stock in the form of restricted stock units (RSUs) at no cash cost. These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, if she continues serving on the Board of Directors through that date. After this grant, she reports beneficial ownership of 78,682 shares of Common Stock, reflecting her total direct position as of this filing.
Miller Perkins reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Miller Perkins reported receiving 13,626 shares of Common Stock in the form of restricted stock units (RSUs). These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and carry a grant price of $0.00 per share.
The RSUs will vest 100% on April 15, 2027, provided Perkins continues to serve on the company’s Board of Directors through that date. After this grant, Perkins directly holds 50,769 shares of Herbalife common stock.
HERBALIFE LTD. director Des Walsh filed an initial Form 3 to report his beneficial ownership of the company’s common stock. The filing shows indirect ownership of 200,000 shares held "By Trust" and direct ownership of 50,000 shares. This Form 3 records existing holdings rather than new open‑market purchases or sales.
HERBALIFE LTD. president Robert Levy filed an amended Form 3 to correct his reported holdings of common stock. The amendment shows he directly holds 154,145 shares of common stock, including 142,740 shares of deferred common stock that were inadvertently omitted from his original Form 3 and a Form 4 filed on May 5, 2026. This filing updates disclosure of ownership rather than reporting a new stock transaction.
HLF: Notice of proposed resale of 134,982 shares of Common Stock. The filing lists 134,982 shares classified as Restricted Stock Vesting available for sale by the holder, with a listed aggregate value of $1,822,211.46.
The filing also shows 7,937 shares sold in the past three months (trade date 05/11/2026) with proceeds of $110,002.00. Shares outstanding are shown as 103,669,416 as of 05/12/2026.